 However, there is a lack of published data on the clinical utility of NBI in the detection of gastric intestinal metaplasia, dysplasia and EGC in the unselected general population. A recent study from Singapore looked at the utility of NBI and NBI-ME in patients aged 35 to 70 years undergoing diagnostic UGI endoscopy and found that the detection rate of focal lesions was increased from 43.7 to 58.8 with NBI, compared to WLE. Among the additional lesions detected, NBI-ME identified 97.1 as IM, 1.4 as EGC and 1.4 as benign. The EGC was a synchronous cancer missed by WLE but detected by NBI12. 